Biotech entity
Every one of those 1 sits in a single category, funding. JUP common stock is most often covered alongside GlobeNewsWire, which appears in 1 of these 1 story. Each carries 2 original sources on average. We currently track 1 Biotech story that mention JUP common stock, all published on August 21, 2026.
Last mentioned: 2d ago
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, funding. JUP common stock is most often covered alongside GlobeNewsWire, which appears in 1 of these 1 story. Each carries 2 original sources on average. We currently track 1 Biotech story that mention JUP common stock, all published on August 21, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 4 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering JUP common stock. Shared-story counts are live from our verified record — not editorial picks.
Jupiter Neurosciences priced a $2.0 million registered direct offering on August 21, 2026, marking another micro-cap financing in a squeezed biotech market. The raise may provide operational runway but introduces dilution and signals limited access to larger capital.
Source: manilatimes.net · Seeking Alpha
JUP common stock is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
